We are live on
!
Find out more
Plus Therapeutics
PSTV
PSTV
11 hedge funds and large institutions have $1M invested in Plus Therapeutics in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
451% more capital invested
Capital invested by funds: $182K → $1M (+$820K)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
22% more funds holding
Funds holding: 9 → 11 (+2)
0.38% more ownership
Funds ownership: 0.09% → 0.48% (+0.38%)
Holders
11
Holders Change
+2
Holders Change %
+22.22%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$1.12M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$34.1K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$14.9K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$6.28K |
| 5 |
ATPW
Ashton Thomas Private Wealth
Scottsdale,
Arizona
|
+$1.62K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$31K |
| 2 |
Wells Fargo
San Francisco,
California
|
-$63 |